Home › NDC Lookup › RxCUI directory › RxCUI 309985

250 ML dobutamine 1 MG/ML Injection — RxCUI 309985

RxNorm drug concept · Semantic clinical drug
RxCUI 309985 Semantic clinical drug · SCD ● Current RxNorm concept 9 FDA products 9 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI309985
Official name250 ML dobutamine 1 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asdobutamine 250 MG per 250 ML Injection; DOBUTamine 250 MG in 250 ML Injection; dobutamine (as dobutamine HCl) 250 MG per 250 ML Injection
FDA products mapped9
Package NDCs mapped9
Reported Medicaid activity (SDUD)2,790 prescriptions · 32 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Dobutamine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It gives short-term support to a weak heart. It is used when the heart cannot pump well because of organic heart disease or after heart surgery. It is not for long-term heart failu...
  • It is given through an IV by your care team. They start at a low rate and adjust it every few minutes while watching your blood pressure, heart rate and urine output. You do not ta...
  • A faster heartbeat and higher blood pressure are common. Some people have extra heartbeats, nausea, headache, chest pain or shortness of breath. Tell your nurse if you feel any of...
  • Say something if you have chest pain, a racing heartbeat, trouble breathing, dizziness, rash, wheezing, or pain or swelling at the IV site. The dose can often be lowered if there i...
📖 Read our full Dobutamine guide →

🕸️ Concept Web — How 250 ML dobutamine 1 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 250 ML dobutamine 1 MG/ML Injection RxCUI 309985

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Dobutamine 3616
  2. Dose forms 4

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Dobutamine Injection 1812167
    • Dobutamine Injectable Product 1159604
    • Injection 1649574
    • Injectable Product 1151126
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Dobutamine 1 MG/ML 328217

Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Dobutamine 1 MG/ML SCDC · 328217
  • Dobutamine Injection SCDF · 1812167
  • Dobutamine Injectable Product SCDG · 1159604

📦 FDA Products & Package NDCs

9 products · 9 package NDCs
9 package NDCs map to RxCUI 309985 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00338-1073-02 18 BAG in 1 CARTON (0338-1073-02) / 250 mL in 1 BAG Dobutamine Hydrochloride in Dextrose Baxter Healthcare Corporation 1993-09-27
00338-1075-02 18 BAG in 1 CARTON (0338-1075-02) / 250 mL in 1 BAG Dobutamine Hydrochloride in Dextrose Baxter Healthcare Corporation 1993-09-27
00338-1077-02 18 BAG in 1 CARTON (0338-1077-02) / 250 mL in 1 BAG Dobutamine Hydrochloride in Dextrose Baxter Healthcare Corporation 1993-09-27
00409-0025-10 12 POUCH in 1 CASE (0409-0025-10) / 1 BAG in 1 POUCH / 250... Dobutamine in Dextrose Hospira, Inc. 2026-03-16
00409-0151-10 12 POUCH in 1 CASE (0409-0151-10) / 1 BAG in 1 POUCH / 250... Dobutamine in Dextrose Hospira, Inc. 2026-03-16
00409-1100-10 12 POUCH in 1 CASE (0409-1100-10) / 1 BAG in 1 POUCH / 250... Dobutamine in Dextrose Hospira, Inc. 2026-03-16
51662-1566-01 250 mL in 1 BAG (51662-1566-1) DOBUTAMINE HYDROCHLORIDE HF Acquisition Co LLC, DBA HealthFirst 2021-07-10
51662-1664-01 250 mL in 1 BAG (51662-1664-1) DOBUTAMINE IN DEXTROSE HF Acquisition Co. LLC, DBA HealthFirst 2005-08-12
51662-1697-01 250 mL in 1 BAG (51662-1697-1) DOBUTAMINE IN DEXTROSE HF Acquisition Co LLC, DBA HealthFirst 2026-03-16
Observed labelers: Baxter Healthcare Corporation (3) · Hospira, Inc. (3) · HF Acquisition Co LLC, DBA HealthFirst (2) · HF Acquisition Co. LLC, DBA HealthFirst (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J1250 Inj dobutamine hcl/250 mg 4 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.